Table 1 Demographic and pre-procedure clinical characteristics
From: Outcomes following percutaneous coronary revascularization among South Asian and Chinese Canadians
Variablea | All | Ethnicity | p-value | ||
|---|---|---|---|---|---|
SA (n = 3904) | Chinese (n = 1345) | Other (n = 36,543) | |||
Male | 30047 (71.9) | 2741 (70.2) | 1018 (75.7) | 26288 (71.9) | <0.001 |
Age | 64 (56, 73) | 62 (53.5, 71) | 65 (56, 74) | 64 (56, 74) | <0.001 |
BMI, kg/m2 | 27.3 (24.6, 30.5) | 26.2 (23.9, 29.1) | 24.5 (22.4, 26.7) | 27.5 (24.9, 30.8) | <0.001 |
Elective | 9534 (22.9) | 900 (23.1) | 362 (27.1) | 8272 (22.7) | <0.001 |
Indication | |||||
ACS Stable angina Other | 30115 (72.3) 9877 (23.7) 1662 (4.0) | 2780 (71.4) 976 (25.1) 140 (3.6) | 866 (64.5) 416 (31.0) 60 (4.5) | 26469 (72.7) 8485 (23.3) 1462 (4.0) | <0.001 |
Medications within 24 h prior to procedure | |||||
ASA ACE-I Statins | 38030 (91.0) 20294 (48.6) 24910 (59.6) | 3543 (90.8) 1735 (44.4) 2306 (59.1) | 1156 (85.9) 524 (39) 751 (55.8) | 33331 (91.2) 18035 (49.4) 21853 (59.8) | <0.001 <0.001 0.011 |
Congestive heart failure | 2320 (5.6) | 232 (5.9) | 84 (6.3) | 2004 (5.5) | 0.260 |
Prior MI | 7094 (17) | 580 (14.9) | 169 (12.6) | 6345 (17.4) | <0.001 |
HTN | 23744 (56.8) | 2310 (59.2) | 892 (66.3) | 20542 (56.2) | <0.001 |
Dyslipidemia | 22346 (53.5) | 2281 (58.4) | 751 (55.8) | 19314 (52.9) | <0.001 |
CBVD | 2762 (6.6) | 203 (5.2) | 85 (6.3) | 2474 (6.8) | 0.01 |
Diabetes Mellitus | 8817 (21.1) | 1204 (30.8) | 353 (26.2) | 7260 (19.9) | <0.001 |
Dialysis | 520 (1.2) | 56 (1.4) | 28 (2.1) | 43 (1.2) | 0.008 |
LVEF | |||||
> 50% 30–50% < 30% Not entered | 20570 (49.2) 15893 (38.0) 1065 (2.6) 4264 (10.2) | 2128 (54.5) 1285 (32.9) 129 (3.3) 362 (9.3) | 715 (53.2) 429 (31.9) 36 (2.6) 165 (12.3) | 17727 (48.5) 14179 (38.8) 900 (2.5) 3737 (10.2) | <0.001 |
Smoking status | |||||
Current | 9149 (21.9) | 445 (11.4) | 185 (13.8) | 8519 (23.3) | <0.001 |
Former | 15926 (38.1) | 546 (14) | 357 (26.5) | 15023 (41.1) | |
Never | 16717 (40) | 2913 (74.6) | 803 (9.7) | 13001 (35.6) | |
PVD | 2847 (6.8) | 120 (3.1) | 46 (3.4) | 2681 (7.3) | <0.001 |
Pulmonary disease | 4190 (10) | 304 (7.8) | 82 (6.1) | 3804 (10.4) | <.0001 |
Liver-GI | 3492 (8.4) | 305 (7.8) | 105 (7.8) | 3082 (8.4) | 0.3126 |
Malignancy | 2898 (6.9) | 126 (3.2) | 63 (4.7) | 2709 (7.4) | <.0001 |
3-vessel or left main disease | 9445 (22.7) | 1009 (26.1) | 356 (26.7) | 8080 (22.4) | <0.001 |